Since ROS associated oxidative stress has been proven to play important roles in several cancer types and served as promising target for therapy (Perše, 2013; Sosa et al., 2013), we hypothesized that dysregulated ROS levels provide a second signal for CCS-induced proliferation and migration in breast cancer cells. The gene discussed is CCS; the disease is breast cancer.